MedTrace Logo

Life Style Modifications Prevents Type 2 Diabetes in Asian Indians

NCT00279240 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2006-01-24

No results posted yet for this study

Summary

Three year prospective randomised controlled trial in IGT subjects to study the effect of metformin and lifestyle modification in preventing the conversion to diabetes

Conditions

Interventions

DRUG

Metformin

Sponsors & Collaborators

  • M.V. Hospital for Diabetes

    lead OTHER

Principal Investigators

  • Ambady Ramachandran, MD,PhD,DSc. · Director

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-03-31
Completion
2004-12-31

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00279240 on ClinicalTrials.gov